Olema Pharmaceuticals, Inc.

General ticker "OLMA" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $526.0M (TTM average)

Olema Pharmaceuticals, Inc. does not follow the US Stock Market performance with the rate: -2.5%.

Estimated limits based on current volatility of 6.0%: low 4.91$, high 5.55$

Factors to consider:

  • Earnings expected soon, date: 2025-05-14 bmo
  • Price in estimated range

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2024-12-31 to 2026-12-31

  • 2024-12-31 to 2025-12-31 estimated range: [2.94$, 7.81$]
  • 2025-12-31 to 2026-12-31 estimated range: [2.18$, 5.85$]

Financial Metrics affecting the OLMA estimates:

  • Negative: Non-GAAP EPS, $ of -2.21 <= 0.04
  • Negative: Operating cash flow per share per price, % of -17.89 <= 1.79
  • Negative: negative Net income
  • Negative: negative Operating income
  • Positive: Inventory ratio change, % of 0 <= 0
  • Positive: Interest expense per share, $ of 0 <= 0
  • Negative: Industry operating cash flow per share per price (median), % of -21.10 <= 2.82
  • Negative: negative Industry operating income (median)
  • Positive: Shareholder equity ratio, % of 90.68 > 63.75

Similar symbols

Short-term OLMA quotes

2025-03-252025-03-262025-03-272025-03-282025-03-312025-04-012025-04-022025-04-032025-04-042025-04-072025-04-082025-04-092025-04-102025-04-112025-04-142025-04-152025-04-162025-04-172025-04-212025-04-222025-04-232025-04-242025-04-252025-04-282025-04-292025-04-302025-05-012025-05-022025-05-052025-05-0633.544.555.5
Price $

Long-term OLMA plot with estimates

24681012141618Jul 2023Jan 2024Jul 2024Jan 2025Jul 2025Jan 2026Jul 2026Jan 2027−0.6−0.4−0.20
OLMAS&P500Health CareNon-GAAP EPS EstimateNon-GAAP EPS ActualPrice $Non-GAAP EPS $

Financial data

YTD 2022-12-31 2023-12-31 2024-12-31
Operating Revenue $0.00MM $0.00MM $0.00MM
Operating Expenses $106.99MM $104.96MM $142.26MM
Operating Income $-106.99MM $-104.96MM $-142.26MM
Non-Operating Income $2.20MM $8.31MM $12.78MM
R&D Expense $82.27MM $86.14MM $124.52MM
Income(Loss) $-104.79MM $-96.66MM $-129.47MM
Profit(Loss)* $-102.59MM $-96.66MM $-129.47MM
Stockholders Equity $197.55MM $253.90MM $408.96MM
Inventory $0.32MM $0.00MM $0.00MM
Assets $215.65MM $276.94MM $450.98MM
Operating Cash Flow $-82.06MM $-83.73MM $-104.35MM
Capital expenditure $0.36MM $0.00MM $0.00MM
Investing Cash Flow $91.48MM $-4.85MM $-93.53MM
Financing Cash Flow $0.48MM $133.41MM $268.82MM
Earnings Per Share** $-2.56 $-2.14 $-2.20

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.